DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Provention Bio Q4 EPS $(0.22) Beats $(0.24) Estimate

Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is a 46.67 percent decrease over losses of $(0.15) per share from the

Benzinga · 03/12/2020 11:07

Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is a 46.67 percent decrease over losses of $(0.15) per share from the same period last year.